Raghav Aggarwal is currently a Vice President at BGR, a policy and public relations firm.

Prior to joining BGR, Raghav held a variety of senior roles with the Department of Health and Human Services (HHS), Centers for Medicare & Medicaid Services (CMS) over a period spanning three different administrations. Most recently, as Senior Advisor, he helped oversee a vast array of policy and operational work related to the $400 billion Medicare Advantage and Part D programs, including implementation of the drug pricing and payment reform provisions of the Inflation Reduction Act of 2022 (IRA).

Previously, Raghav served on the Majority Staff of the U.S. Senate Committee on Finance, on detail from CMS as Senior Health Policy Advisor. In that role, he managed legislation and advised Chairman Ron Wyden (D-OR) on the prescription drug pricing, Medicare Part D, and Medicare Advantage policy portfolios, among other health care issues. Raghav most notably led the development of the IRA’s drug pricing and payment reform provisions and helped to successfully negotiate passage of the landmark legislation that he also eventually helped implement.

Raghav has received numerous honors and awards for his meaningful contributions to federal health care policy, including the HHS Secretary’s Award for Excellence in Management, one of the highest honors granted by the Department and conferred by the Secretary.

Raghav Aggarwal

Vice President at BGR Group
Former Senior Policy Advisor at CMS